Skip to main content
All lobbying clients

GENETIX BIOTHERAPEUTICS, INC.

Lobbying client · Massachusetts · filed 2025 to 2026

Biotechnology and pharmaceutical company.

$705,000 Reported spend
16 Filings counted
3 Outside firms hired
0 Bills named

Spend is reported income plus in-house expenses across 16 filings. 1 further filing for this client was restated by a later amendment and is left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 3 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as GENETIX BIOTHERAPEUTICS, GENETIX BIOTHERAPEUTICS INC.

 Who filed for this client 3

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Reported by year 2 years
  • 2026 $425,000 8 filings
  • 2025 $280,000 8 filings
 Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 4
  • HOUSE OF REPRESENTATIVES 12
  • SENATE 12
  • Food & Drug Administration (FDA) 4
  • Health & Human Services, Dept of (HHS) 3
 Recent filings 17 total
Q3 report
ARNOLD & PORTER KAYE SCHOLER LLP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 19, 2026
View → Q3 report
JEFFREY J. KIMBELL & ASSOCIATES, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $15,000 income · posted Oct 18, 2026
View → Q2 termination
BALLARD PARTNERS
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $80,000 income · posted Oct 16, 2026
View → Q2 report
JEFFREY J. KIMBELL & ASSOCIATES, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $15,000 income · posted Jul 20, 2026
View → Q2 report
ARNOLD & PORTER KAYE SCHOLER LLP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 17, 2026
View → Q2 report
BALLARD PARTNERS Amended
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $120,000 income · posted Jul 15, 2026
View → Q1 report
JEFFREY J. KIMBELL & ASSOCIATES, INC.
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $15,000 income · posted Apr 20, 2026
View → Q1 report
ARNOLD & PORTER KAYE SCHOLER LLP
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 17, 2026
View → Q1 report
BALLARD PARTNERS
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $120,000 income · posted Apr 15, 2026
View → Q4 reportNo activity
JEFFREY J. KIMBELL & ASSOCIATES, INC.
4th Quarter 2025 (Oct 1 - Dec 31) · posted Jan 20, 2026
View → Q4 report
ARNOLD & PORTER KAYE SCHOLER LLP
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $60,000 income · posted Jan 14, 2026
View → Q4 reportNo activity
BALLARD PARTNERS
4th Quarter 2025 (Oct 1 - Dec 31) · $40,000 income · posted Jan 14, 2026
View → Registration
JEFFREY J. KIMBELL & ASSOCIATES, INC.
4th Quarter 2025 (Oct 1 - Dec 31) · posted Jan 9, 2026
View → Registration
BALLARD PARTNERS
4th Quarter 2025 (Oct 1 - Dec 31) · posted Dec 29, 2025
View → Q3 report
ARNOLD & PORTER KAYE SCHOLER LLP
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 15, 2025
View → Q2 report
ARNOLD & PORTER KAYE SCHOLER LLP
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 17, 2025
View → Q1 report
ARNOLD & PORTER KAYE SCHOLER LLP
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 17, 2025
View →

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem